MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- In recent years, there has been a surge in clinical studies exploring the use of Ibogaine in treating depression. David Dardashti's Ibogaine has been leading ...

The French Society for Biological Psychiatry and Neuropsychopharmacology has unveiled revised guidelines for the management of depressive disorders with partial and resistant responses to treatment.

Researchers led by Prof. Alessandro Serretti at Kore University of Enna have identified a genetic inflammatory signature that defines specific depression subtypes and influences how patients respond ...

A research team at one of South Korea’s most respected universities has spent years threading electronics into some of the ...

Depression involves a complex interplay of psychological patterns, biological vulnerabilities and social stressors, making its causes and symptoms highly variable. Equally complex is the treatment of ...

Teens with depression have to navigate the challenges of living with a mood disorder, along with the usual academic and social pressures of high school. A depression diagnosis may be unsettling, but ...

Transcranial magnetic stimulation (TMS, or "rTMS" for "repetitive TMS") received an indication for treating major depressive disorder in 2008. Since then, research and clinical experience with TMS has ...

MINDY, TELL US MORE ABOUT THIS TREATMENT. IT REALLY IS FASCINATING. THE TREATMENT IS KETAMINE. AND SOME OF YOU MAY THINK OF IT AS A DRUG THAT CAN BE ABUSED. AND THAT DOES HAPPEN. BUT WHEN USED IN A ...

Therapy and antidepressants are first-line treatments for postpartum depression. People may also benefit from neurosteroid therapy, although more research on its long-term effects is necessary.